OVO LASIK + Lens
This is a prospective, single-site, two-surgeon, single-arm, observational study evaluating the Clareon TruPlus IOL. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the IOLSAT Questionnaire.
Inclusion Criteria: * Willing and able to understand and sign informed consent. * Adult patients (\>40 years old) undergoing age-related cataract surgery with expected best-corrected visual outcomes of 20/25 or better in both eyes pre-operatively as determined by surgeon and with regular corneal astigmatism correctable to less than 0.75 diopters post-operatively with no more than a T6 toric power IOL. * Normal ocular findings aside from cataract and mild dry eye. Exclusion Criteria: * Subjects targeted for monovision. * Moderate-severe corneal pathology, irregular astigmatism, preexisting m…
Clareon TruPlus
Arctuva estimate
Verify or correct the compensation shown for this listing.